• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Aurobindo Pharma Ltd.
    06 Aug 2025
    USFDA Observation
    1036.00
    0.11%
    Aurobindo Pharma Q1 Results Review: Motilal Oswal Maintains 'Buy' Check Target Price
    Aurobindo Pharma Q1 Results Review: Motilal Oswal Maintains 'Buy' Check Target Price
    NDTV Profit
    Recent hiccups related to manufacturing plant issues and tariff uncertainties have led to volatility in earnings and, subsequently, the stock price, adds the brokerage.
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. has an average target of 1403.50 from 10 brokers.
    logo
    Orchid Pharma Ltd.
    05 Aug 2025
    721.60
    -2.45%
    Tesla Leases 33,000 Sq Ft Commercial Space In Gurugram
    Tesla Leases 33,000 Sq Ft Commercial Space In Gurugram
    NDTV Profit
    The Elon Musk-led company has registered a 9-year lease for the unit in Gurugram's Orchid Business Park.
    Copy LinkShare onShare on Share on Share on
    Orchid Pharma Ltd. is trading below all available SMAs
    Tesla leases retail space in Gurgaon for its second showroom in India
    Business Standard | 05 Aug 2025
    logo
    Lupin Ltd.
    05 Aug 2025
    1939.20
    -0.61%
    Lupin Q1 Results: Net Profit Jumps 52% To Rs 1,221 Crore
    Lupin Q1 Results: Net Profit Jumps 52% To Rs 1,221 Crore
    NDTV Profit
    Sales rose to Rs 6,164 crore in the first quarter as against Rs 5,514 crore in the year-ago period, Lupin Ltd said in a statement.
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. is trading below its 100 day SMA of 1970.6
    Lupin Q1 results: Net profit jumps 52% to 1,221 cr on strong sales in US
    Business Standard | 05 Aug 2025
    logo
    Advanced Enzyme Technologies Ltd.
    05 Aug 2025
    342.05
    0.88%
    Broker's call: Advanced Enzyme (Buy)
    Business Line
    Centrum Broking
    Copy LinkShare onShare on Share on Share on
    Institutional Investors have increased holdings from 20.09% to 31.90% in Jun 2025 qtr.
    logo
    Alembic Pharmaceuticals Ltd.
    05 Aug 2025
    Insider Trades
    960.10
    0.46%
    Alembic Pharmaceuticals first-quarter profit jumps to 154.27 on strong US, domestic sales
    Business Line
    India's generic drugmakers have been facing margin pressures due to lower prices in the US amid fierce competition
    Copy LinkShare onShare on Share on Share on
    Alembic Pharmaceuticals Ltd. is trading above its 200 day SMA of 955.5
    logo
    Aurobindo Pharma Ltd.
    05 Aug 2025
    USFDA Observation
    1036.00
    0.11%
    Aurobindo Pharma stock falls 2% after Q1 results; check key numbers here
    Business Standard
    Aurobindo Pharma's net profit fell 10.2 per cent Y-o-Y to 824 crore in Q1FY26, as against 918 crore in the same quarter last year
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. has an average target of 1403.50 from 10 brokers.
    Aurobindo Pharma Q1 PAT falls 10% on drop in API sales, US market revenue
    Business Standard | 05 Aug 2025 4 more
    Aurobindo Pharma Q1 results: Profit drops 10% to 824 crore on US sales
    Business Standard | 04 Aug 2025
    Aurobindo Pharma's Q1 net down 10.2% at 824 cr
    Business Line | 04 Aug 2025
    Aurobindo Pharma Declares Dividend Of Rs 4 Check Record Date, Details
    NDTV Profit | 04 Aug 2025
    Aurobindo Pharma Q1 Results: Profit Falls 10%, Misses Estimates
    NDTV Profit | 04 Aug 2025
    logo
    Sanofi Consumer Healthcare India Ltd.
    04 Aug 2025
    5210.00
    1.73%
    Sanofi Consumer Healthcare Q2 - driven by exports, product launches
    Business Line
    Quarter and half-year financials are not directly comparable due to the demerger and voluntary recall of certain variants of key brands, the company said
    Copy LinkShare onShare on Share on Share on
    Promoters have increased holdings from 60.40% to 71.27% in Jun 2025 qtr.
    logo
    Emcure Pharmaceuticals Ltd.
    04 Aug 2025, 12:39PM
    1370.70
    -0.05%
    Emcure Pharma shares gain as JM Financial initiates coverage; check target
    Business Standard
    JM Financial initiated coverage on Emcure Pharma with a 'Buy' rating and a target price of 1,740, citing its growth prospects
    Copy LinkShare onShare on Share on Share on
    Emcure Pharmaceuticals Ltd. is trading above its 200 day SMA of 1244.4
    logo
    Dr. Reddy's Laboratories Ltd.
    04 Aug 2025, 10:01AM
    1253.00
    -0.73%
    Dr. Reddy's Laboratories Price Target Cut By Citi Over Intensifying Generic Competition Full Details
    Dr. Reddy's Laboratories Price Target Cut By Citi Over Intensifying Generic Competition Full Details
    NDTV Profit
    Citi notes that market expectations for Dr. Reddy's Semaglutide opportunity may be too optimistic.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    logo
    GlaxoSmithKline Pharmaceuticals Ltd.
    01 Aug 2025
    2851.80
    2.70%
    GSK Pharma on track to bring in its oncology products Jemperli and Zejula
    Business Line
    Bhushan Akshikar, GSK Pharma Managing Director said the company would invest in its innovative portfolio and was on track to launch its oncology assets, Jemperli (dostarlimab) and Zejula (niraparib)
    Copy LinkShare onShare on Share on Share on
    GlaxoSmithKline Phar.. has an average target of 2800.00 from 2 brokers.
    GSK Pharma Q1 results: PAT rises 12% to 279 cr, income declines marginally
    Business Standard | 01 Aug 2025
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd